These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23180453)

  • 1. Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).
    Knopf H; Hölling H; Huss M; Schlack R
    BMJ Open; 2012; 2(6):. PubMed ID: 23180453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003-2006 and 2009-2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1)].
    Schlack R; Mauz E; Hebebrand J; Hölling H;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jul; 57(7):820-9. PubMed ID: 24950831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
    Schlack R; Hölling H; Kurth BM; Huss M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):827-35. PubMed ID: 17514469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS).
    Huss M; Hölling H; Kurth BM; Schlack R
    Eur Child Adolesc Psychiatry; 2008 Dec; 17 Suppl 1():52-8. PubMed ID: 19132304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study.
    Döpfner M; Breuer D; Wille N; Erhart M; Ravens-Sieberer U;
    Eur Child Adolesc Psychiatry; 2008 Dec; 17 Suppl 1():59-70. PubMed ID: 19132305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medicine use in children and adolescents. Data collection and first results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
    Knopf H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):863-70. PubMed ID: 17514472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    Meyer T; Becker A; Sundermann J; Rothenberger A; Herrmann-Lingen C
    Eur Child Adolesc Psychiatry; 2017 Feb; 26(2):165-175. PubMed ID: 27197525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of medicines and nutritional supplements in childhood and adolescence in Germany : Results from KiGGS Wave 2].
    Knopf H; Sarganas G; Grams D; Du Y; Poethko-Müller C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Oct; 62(10):1215-1224. PubMed ID: 31529182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mental health module (BELLA study) within the German Health Interview and Examination Survey of Children and Adolescents (KiGGS): study design and methods.
    Ravens-Sieberer U; Kurth BM; ;
    Eur Child Adolesc Psychiatry; 2008 Dec; 17 Suppl 1():10-21. PubMed ID: 19132300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.
    Xu G; Strathearn L; Liu B; Yang B; Bao W
    JAMA Netw Open; 2018 Aug; 1(4):e181471. PubMed ID: 30646132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of long-term ADHD medication use in Australian children.
    Efron D; Mulraney M; Sciberras E; Hiscock H; Hearps S; Coghill D
    Arch Dis Child; 2020 Jun; 105(6):593-597. PubMed ID: 31937570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    McCarthy S; Neubert A; Man KKC; Banaschewski T; Buitelaar J; Carucci S; Coghill D; Danckaerts M; Falissard B; Garas P; Häge A; Hollis C; Inglis S; Kovshoff H; Liddle E; Mechler K; Nagy P; Rosenthal E; Schlack R; Sonuga-Barke E; Zuddas A; Wong ICK
    BMC Psychiatry; 2018 Oct; 18(1):327. PubMed ID: 30305167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
    Rast JE; Anderson KA; Roux AM; Shattuck PT
    Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study.
    Pinho R; Wang B; Becker A; Rothenberger A; Outeiro TF; Herrmann-Lingen C; Meyer T
    World J Biol Psychiatry; 2019 Jul; 20(6):496-504. PubMed ID: 29243550
    [No Abstract]   [Full Text] [Related]  

  • 16. ADHD in children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends.
    Göbel K; Baumgarten F; Kuntz B; Hölling H; Schlack R
    J Health Monit; 2018 Sep; 3(3):42-49. PubMed ID: 35586800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing psychopathological problems of children and adolescents from 3 to 17 years in a nationwide representative sample: results of the German health interview and examination survey for children and adolescents (KiGGS).
    Hölling H; Kurth BM; Rothenberger A; Becker A; Schlack R
    Eur Child Adolesc Psychiatry; 2008 Dec; 17 Suppl 1():34-41. PubMed ID: 19132302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erratum to: Application of medicines and nutritional supplements in childhood and adolescence in Germany].
    Knopf H; Sarganas G; Grams D; Du Y; Poethko-Müller C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Oct; 63(10):1287-1296. PubMed ID: 32246159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
    Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.